In order to design a feasible somatic cell gene delivery sysgogues. While glucose responsiveness commenced at a tem for the treatment of type I diabetes, a suitable cell type lower concentration than normal islets, a secretion curve needs to be determined. We have previously shown that approaching normal physiological conditions was generthe stable transfection of the full-length insulin cDNA into ated. Immunoelectron microscopy revealed the presence the human liver cell line, (HEP G2ins) resulted in synthesis, of insulin-containing granules, similar in size and appearstorage and acute regulated release of insulin to analogues ance to those of the normal beta cell. These results demof cAMP, but not to the physiological stimulus glucose. In onstrate that while it is most likely that the HEP G2ins/g attempting to explain the lack of glucose responsiveness cell line predominantly secretes insulin via the constitutive of the HEP G2ins cells we have stably transfected these pathway, significant acute regulated release was seen in cells with the human islet glucose transporter GLUT 2 response to glucose, and thus represents significant pro-(HEP G2ins/g cells). The HEP G2ins/g cell clones exhibit gress in the creation of a genetically engineered 'artificial glucose-stimulated insulin secretion and glucose potentibeta cell' from a human hepatocyte cell line. ation of the secretory response to nonglucose secreta-
Introduction
cally active insulin can be generated from a transgenic Type I or insulin-dependent diabetes mellitus (IDDM) animal model in which the insulin gene was controlled results from the autoimmune destruction of the insulinby the p-enolpyruvate carboxylase promoter 2 lends producing beta cells of the pancreas. 1 Permanent correccredence to this choice. tion of IDDM by pancreas transplantation is restricted by An earlier study by our group 3 revealed that the stable the availability of normal human pancreatic tissue, diffitransfection of insulin cDNA into a liver cell line (HEP culties in the prevention of its rejection once grafted, and G2ins) resulted in synthesis, storage and chronic release by the potential for further autoimmune damage to the of insulin via the constitutive pathway. Acute regulated transplanted pancreas. Moreover, substantial morbidity, release of insulin to analogues of cAMP, but not to the due to life-long immunosuppressive therapy, inevitably physiological stimulus of glucose was also demonstrated. follows pancreas transplantation. Some of these problems
The parental HEP G2 cells express the erythrocyte/brain may be overcome by engineering, from the patient's own glucose transporter GLUT 1, 4 but do not express the cells, an 'artificial beta cell', ie a non-islet cell capable of liver/islet glucose transporter GLUT 2. 5 This facilitative synthesising, storing and secreting mature insulin in transporter has a low affinity for glucose but a high response to metabolic signals, thus correcting diabetes capacity for transport. Consequently, the rate of glucose without the need for immunosuppression. Of the cell uptake by normal beta cells changes in direct proportion types available we are examining hepatocytes because to the glucose concentration and is not rate limiting at they play a crucial role in intermediary metabolism, synphysiological concentrations. 6, 7 It is well documented that thesis and storage of metabolic products and exhibit glusignificant reduction of GLUT 2 mRNA and protein cokinase and glucose transporter expression similar to levels leads to the loss of glucose-stimulated insulin secretion, linking GLUT 2 to the regulation of insulin secretion. 8, 9 GLUT 2 has been shown to be of paramount RIN 1046-38 cells, which lose glucose-stimulated insulin secretion with continual passaging in culture. Return of glucose sensitivity in these cells required exogenous overexpression of both the GLUT 2 and glucokinase genes. Stable transfection of rat GLUT 2 and insulin cDNA into the mouse pituitary adenoma cell AtT20 which normally express glucokinase, resulted in increased intracellular storage of insulin, glucose potentiation of nonglucose secretagogues and direct stimulation of insulin release by glucose. 11 However, the maximal effect of glucose on insulin secretion was seen at nonphysiological concentrations of glucose in the micromolar range. In this report, we describe how the glucose unresponsiveness of HEP G2ins cells was corrected by the stable transfection of human GLUT 2 cDNA, and have evaluated insulin storage and secretion in these cells.
Results
Gene transfer into hepatoma cells HEP G2ins cells (previously transfected with the pRcCMV vector carrying insulin cDNA) 3 were stably transfected with the pREP4 vector carrying human GLUT 2 cDNA. Four clones (HEP G2ins/g cells) were isolated, two of which were selected for further analysis, because their levels of insulin secretion and storage were the greatest. Both of these clones were screened for overexpression of GLUT 2 and characteristics of glucoseresponsive insulin expression. The transfectants have remained stable for a period of greater than 6 months. Unless otherwise stated, control cells in all experiments are HEP G2 cells transfected with the empty pRcCMV and pREP 4 vectors alone. 
HEP G2ins cells (transfected with insulin cDNA alone).
Insulin mRNA was overexpressed in HEP G2ins and HEP G2ins/g cells and absent from controls. To deterand 1.4-fold increase in intracellular insulin content mine whether the GLUT 2 protein was indeed expressed respectively (Table 1) compared with the parental HEP in the HEP G2ins/g cells, Western blots of membranes G2ins cells lacking GLUT 2. As expected clones without were probed with an antiserum raised against human insulin or GLUT 2 showed no insulin expression. The GLUT 2. This antiserum detected a protein of 55 kDa in proportion of insulin:proinsulin was also greater (11.1:1, the HEP G2ins/g cells, having identical electrophoretic clone 1; 8:1, clone 2) in the HEP G2ins/g cells, compared mobility to GLUT 2 in pancreatic islets. 12 This protein with 3.6:1 in the HEP G2ins line. In both HEP G2ins/g was absent from the HEP G2 (untransfected cells), HEP and HEPG2ins cells, insulin rather than proinsulin was G2 control cells (transfected with pRcCMV and pRep 4 the predominant hormone stored. vectors alone) and HEP G2ins cells (transfected with Immunohistochemical analysis using a polyclonal antiinsulin cDNA alone) (Figure 1b) . body further confirmed that (pro)insulin was being stored by the HEP G2ins/g cells ( Figure 2 ). Electron microscopy of HEP G2ins/g cells (Figure 3a and b) Chronic secretion and storage of insulin To examine the form of insulin secreted by the HEP revealed the presence of all the normal structures seen in the cytoplasm of hepatoma cells -mitochondria, interG2ins/g cells insulin and proinsulin assays were carried out. It can be seen from Table 1 , that three times more mediate filaments, polysomes, rough endoplasmic reticulum, Golgi complex and lipid. In addition, the HEP proinsulin than insulin was released daily into the medium by the transformed HEP G2ins/g cells. By comG2ins/g cells also contained membrane-bound, electrondense heterogenous structures of approximate diameter parison the parental HEP G2ins cell line chronically secreted a greater proportion of proinsulin (× 6) com-350 nm (347 nm ± 51 s.d.) (Figure 3a) , similar in size and resembling the secretory granules of normal pancreatic pared with insulin. Albumin secretion of the transformed cells (5.1 g/10 5 cells per day ±0.9 s.e., n = 5) was beta cells. [13] [14] [15] These granules were previously described in the HEP G2ins cell line. 16 Large membrane-bound unaltered from untransformed cells (5.2 g/10 5 cells per day ± 0.4 s.e., n = 5).
vacuoles, approximately 0.9 m diameter, containing moderately electron dense material were also present in HEP G2ins/g clone 1 and 2 also demonstrated a 2.7- the cytoplasm of HEP G2ins/g cells ( Figure 3a) . Similar all the final experimentation was carried out using HEP G2ins/g clone 1. In response to varying concentrations of vacuoles were also found in the HEP G2ins cells. 3, 16 No granules or vacuoles were seen in the HEP G2 control glucose from 0-20 mm, a dose-response curve for insulin secretion was generated ( Figure 7 ). While glucose responcells. The formation of immature granules from the maturing face of the Golgi complex, their condensation and siveness commenced at a slightly lower concentration than normal islets, a secretion curve approaching normal presumed fusion to form large (approximately 350 nm), heterogeneous mature granules is seen in Figure 3b .
physiological conditions was generated.
In normal islets, glucose potentiates the insulin Immunoelectron microscopy revealed insulin was specifically being stored in the granules (Figure 4a) . secretory response to various beta cell secretagogues including agents that increase cAMP. 17, 18 Glucose had no These granules containing immunoreactive insulin were present in both the large vacuoles that have previously potentiating effect on 8-Br-cAMP-stimulated insulin release from parental HEP G2ins cells (Table 2 ). Howbeen described in the HEP G2ins cell line 3, 16 and in the body of the cell, similar to that seen in a normal beta ever, glucose had a significant (P Ͻ 0.05) potentiating effect on 8-Br-cAMP-stimulated insulin release from cell [13] [14] [15] and NIT-1 insulinoma cells (Figure 4b ), used as controls for the immunogold technique. No nonspecific GLUT 2-transfected HEP G2ins/g cells ( Table 2) . Similar potentiating effects were seen in the presence of 10 mm labelling was observed on cell nuclei. Control HEP G2 cells were negative as were HEP G2ins/g and NIT-1 cells theophylline (results not shown). The static stimulation experiments simply tell us what in the absence of the first antibody.
As a control experiment, to test whether the granules insulin secretion has taken place over an hour. In order to investigate the dynamics of the insulin secretory response and vacuoles observed in the HEP G2ins/g cells were formed as a result of insulin/proinsulin in the conperifusion experiments were carried out, the results of which are illustrated in Figure 8 . It can be seen from this ditioned culture medium, parental HEP G2 cells were cultured in MEM medium containing insulin, proinsulin
Figure that there is a definite increase in insulin secretion on addition of 20 mm glucose, which returns to basal levor insulin together with proinsulin, at the concentrations found in conditioned media. On examination by TEM no els on removal of the stimulus. There was no distinction between the classical first and second phase of insulin granules or vacuoles developed in the parental HEP G2 cell line following such culture.
secretion.
No glucokinase activity was detected in any of the cell lines by glucose phosphorylation or Northern analysis Acute insulin secretion and glucose phosphorylation Nine times the amount of insulin compared with proin-(results not shown). However, by the more sensitive technique of reverse transcriptase polymerase chain reaction sulin was released acutely following static stimulation with 20 mm glucose for HEP G2ins/g, clone 1 ( Figure 5) ; (RT/PCR) glucokinase expression was detected in human liver tissue (positive control), untransfected HEP the response for HEP G2ins/g clone 2 was smaller, with a stimulation index of 2.0 being recorded. As would be G2 cells and all transfected HEP G2 cells ( Figure 9 ). No glucokinase expression was detected in primary human expected in regulated release, on removal of the stimulus, insulin levels returned to basal. Proinsulin levels fibroblasts, used as a negative control. Hexokinase activity of HEP G2ins/g cells (V max , 14.91 ±1.84 nmol/mg remained unchanged throughout the experiment. Similar results were seen when the cAMP analogue 8-Br-cAMP protein per hour; K m , 0.15 ± 0.05 mm) was unchanged from that of the untransfected HEP G2 cells (V max , and the phosphodiesterase inhibitor, theophylline were applied as a stimulus to HEP G2ins/g, clone 1 ( Figure 6 ).
12.74 ± 0.30; K m , 0.05 ± 0.01) (n = 5). The stimulation indices for HEP G2ins/g, clone 2 were 4.5 and 3.0 in the presence of 8-Br-cAMP and theophylline, respectively. The cells did not respond to 12-O-tetra-(Pro)insulin synthesis In response to varying concentrations of glucose from 0-decanoylphorbol-13-acetate (TPA) or calcium.
As the glucose responsiveness and insulin storage of 20 mm, a dose-response curve was generated for insulin synthesis ( Figure 10 ) with half maximal synthesis HEP G2ins/g clone 1 were superior to those in clone 2,
Figure 2 Light micrographs of (a) HEP G2 cells (negative controls) and (b) HEP G2ins/g cells immunochemically stained for insulin and counterstained with horseradish peroxidase/Mayer's haematoxylin. Granular red, positive staining in cytoplasm of HEP G2ins/g cells is marked with arrows (magnification × 165).
occurring at 5.0 mm glucose and a V max of 44.6 ± 2.4 × 10 3 physiological conditions was generated. Whilst HEP G2ins/g cells are unlike normal beta cells in that chronic c.p.m./g DNA (n = 5).
secretion of predominantly proinsulin takes place presumably via the constitutive pathway, as demonstrated
Discussion
for FAO hepatoma cells transfected with the insulin gene; 19 for the first time regulated release of insulin to the The results presented in this study demonstrate that physiological stimulus glucose has been demonstrated in transfection of human GLUT 2 into the insulin-secreting a liver cell line. These observations represent a step human hepatocyte cell line, HEP G2ins, resulted in acute towards the creation of an 'artificial beta cell' from a stimulation of insulin secretion in response to glucose, non-islet cell line. and a potentiated response to the addition of glucose Transfection of HEP G2ins cells with GLUT 2 signifiplus nonglucose secretagogues. While glucose responcantly increased their intracellular insulin content relative siveness commenced at a slightly lower concentration than normal islets, a secretion curve approaching normal to untransfected cells, and did not alter the amount of insulin chronically secreted, relative to untransfected cells. glucose in the medium); whereas in the transfected HEP G2ins/g cells an increase in insulin content was less, proThis has occurred even though insulin gene expression in HEP G2ins/g cells is not under normal control, and can ducing a 2.7-fold increase in clone 1. The HEP G2ins/g cells were akin to normal beta cells in that they stored most likely be related to increased transport of glucose into the cells as a consequence of GLUT 2 transfection, predominantly insulin and secreted it to an acute stimulus; they also synthesised insulin, as defined by proleading to increased transcription of the insulin gene ( Figure 1a) . Similar results were observed in the AtT20ins duction of 3 H insulin from 3 H leucine in a normal manner. 20, 21 However, the chronic secretion of predominantly cell line on transfection of rat GLUT 2. 11 However, in the AtT20ins cell line the increase in content was of the order proinsulin presumably by the constitutive pathway varies significantly to what is seen in normal beta cells. of four to six times (depending on the concentration of The immuno-electronmicroscopy technique based on microscopy (TEM) as used in the present study, granules have also been noted in the HEP G2ins cell line. 16 The the insulin antibody reaction has revealed the storage of insulin in discrete granules. These granules, although not presence of these granules, may imply that the HEP G2ins/g cell line stores insulin in a manner characteristic identical in appearance, are similar in size (300-350 nm) and resemble the secretory granules of a normal beta of the secretory granules of the islet beta cell and thus may explain how the HEP G2ins/g cell line exhibits regucell [13] [14] [15] and NIT-1 insulinoma cells used as controls in these experiments. Neither granules, nor the large vaculated insulin secretion in a fashion similar to the normal pancreatic beta cell. The process of formation of immaoles are present in normal liver cells or in control HEP G2 cells and are not formed as a result of growth in medium ture granules from the maturing face of the Golgi complex, their condensation and presumed fusion to form containing the levels of insulin/proinsulin produced by these cells in culture. The granules were not documented large (approximately 350 nm), heterogenous mature granules was observed in HEP G2ins/g cells. In a normal in our first publication on the HEP G2ins cells; 3 however, with the improved fixation for transmission electron beta cell, secretory granule formation is thought to occur by proteolytic processing of the secretory proteins and ules in the beta cell and released via the regulated pathway, may also be fully processed, albeit less efficiently retrieval of excess membrane as immature granules fuse together, until the mature granule is formed, 22 and it is by the constitutive pathway conversion machinery. Complete processing of a variety of prohormones via the possible that a similar mechanism is operating in these cells. This however, has not been confirmed and the funcconstitutive pathway has previously been demonstrated upon transfection of the relevant gene in a number of tion of the large (0.9 m), membrane-bound vacuoles, is unclear.
other cell systems. 23, 24 It has not been established in FAO cells which of several endoproteases are responsible for It has been clearly shown in a study by Vollenweider et al, 19 that in the insulin-expressing hepatocyte cell line conversion of proinsulin to insulin via the constitutive pathway. Further studies will determine to what extent FAO, proinsulin, normally processed in secretory gran- the insulin released by HEP G2ins/g cells following static cells. 19 The endoprotease furin 25,26 which has been linked to the processing of proproteins to mature proteins in incubation and perifusion in response to glucose and analogues of cAMP is via constitutive pathways or by a truly several systems is expressed by many tissues and cell lines, including HEP G2 cells 26 and may be involved in regulated route. It will be important also to investigate whether enzymes (PC 2 , PC 3 ) absent from FAO cells 19 are the cleavage of proinsulin to insulin in the present system. It is interesting to note that in a recent study by present in the HEP G2ins/g cells, allowing the greater conversion of proinsulin to insulin than seen in FAO Kolodka et al, 27 where the insulin gene was introduced transfectants to define the disparity between the lack of glucose-responsiveness in primary hepatocytes and our The most important finding of our study was that applied to the same cell line: *P Ͻ 0.05, n = 6. while insulin release from HEP G2ins/g cells commences at a lower glucose concentration (2.8 mm glucose) than that seen in islet cells (4-5 mm), a secretion curve approaching physiological conditions was generated. by a retroviral expression vector into primary rat hepatocytes, no evidence of storage or regulated release of insuThis marks a significant improvement on the AtT20ins cell line 11 that was maximally responsive at 10 m, (50 lin was observed. Possible explanations for our disparate observations are that the HEP G2 cell line alone has times lower than normal). The RT/PCR results for human glucokinase reveal that the HEP G2 parental cell unique properties, such as endoproteases present in the insulin storage granules which allow storage and release; line and all transfectants expressed a low amount of intrinsic glucokinase activity, that was not detected by or the levels of exogenous insulin expression in vivo were lower with the retroviral vector (only 1-10% of the cells Northern analysis or the glucokinase phosphorylation assay. It seems unlikely however, that this level of glucowere successfully transduced) 27 and there is also the difference in species, all previous studies having been kinase expression could be regulating the glucose responsiveness of the HEP G2ins/g cells to near normal physiocarried out in rat liver cells. Furthermore, it will be important to compare the levels of GLUT 1 and GLUT 2 logical levels. With hindsight, it is apparent that the glucokinase activity earlier reported in the HEP G2ins expression in primary hepatocytes and our HEP G2ins/g response did not exhibit a first and second phase characteristic of beta cells, the tightness of the control was clearly exemplified by the immediate switching off of the response on removal of the glucose stimulus. The magnitude of the response to glucose in perifusion was noticeably less than that seen on static incubation, which can be most likely related to the fact that the cells function better in normal culture vessels than grown in suspension attached to cytodex beads.
Whole cell pancreas transplantation and islet cell transplantation have been widely studied as possible strategies for curing IDDM. 31, 32 However, it seems highly unlikely that there will ever be sufficient amounts of human tissue for transplantation to assist more than a selected number of insulin-dependent diabetics, and these would have to be under a regimen of immunosuppressive drugs. This problem could be theoretically overcome by genetically engineering an 'artificial beta cell' capable of storing and secreting insulin in response to metabolic signals. In the current study HEP G2ins cells that store and secrete insulin, but are nonresponsive to glucose, have gained near-physiological glucose responsiveness on transfection of the human GLUT 2 transporter, a great improvement on what has been seen in other engineered cell lines with the possible exception of however apparent that the HEP G2ins/g cells are presumably not achieving glucose responsiveness and proinsulin processing by the exact same mechanism as the norparental cell line 3 with the low K m of 0.1 mm was actually hexokinase activity. Hexokinase is probably not regmal beta cell and it is the subject of future extensive studies on the storage mechanisms, glucose uptake pathulating glucose metabolism directly in the HEP G2ins/g cells, since the K m of this enzyme is at subphysiological ways and channel activity of these cells to fully characterise their secretory mechanisms. However, this does not concentrations of glucose. However, the overexpression of this enzyme relative to glucokinase may indirectly be belittle the significant fact that this study has shown for the first time that glucose-stimulated insulin secretion can responsible for the slight shift to the left of the insulin dose-response curve. 28 One could postulate that a further be engineered in a human liver cell line that possibly with further engineering and appropriate encapsulation transfection with the cDNA for glucokinase might result in a shift of the secretion curve to the right, the K m of could be used as a therapeutic agent for IDDM. GLUT 2 being 7 mm. 29 Alternatively, it can be postulated that the rate-limiting step for insulin secretion is not glu-
Materials and methods
cose phosphorylation but glucose transport. It has been suggested that in some cell lines GLUT 2 may be involved in the metabolic signalling of glucose, in combiMaterials The human GLUT 2 and glucokinase cDNA was kindly nation with signal transduction molecules such as GTPbinding proteins. 30 It is the subject of future work to provided by Professor M Permutt, Washington University, St Louis, MI, USA and the expression vector pREP4 establish the mechanisms of how GLUT 2 confers regulated glucose sensitivity on the HEP G2ins/g cells by gluby Dr M Tycocinski, Case Western Reserve University, Cleveland, USA. Professor B Thorens, Institute of Pharcose uptake studies and an investigation of ATP-dependent K + and voltage-activated Ca 2+ channels on the cell macology and Toxicology, Lausanne, Switzerland provided the antibody to human GLUT 2. The expression surface.
The HEP G2ins/g cells maintained the acute regulated vector pSKII + was purchased form Stratagene (La Jolla, CA, USA). Eagle's minimal essential medium (MEM) and response to agents which raise cAMP levels (8-Br-cAMP and theophylline), seen in the HEP G2ins cells. 3 Howfetal calf serum (FCS) were purchased from Trace Biosciences (Sydney, Australia) and restriction enzymes from ever, unlike normal beta cells the HEP G2ins/g cells remained unresponsive to increased levels of calcium and Boehringer Mannheim (Mannheim, Germany). Hygromycin B, pansorbin and phenylmethylsulfonyl fluoride TPA. Testing the insulin responsiveness of the transfected hepatoma cells to the numerous other normal beta cell (PMSF) were supplied by Calbiochem (La Jolla, CA, USA) and RT/PCR primers for human glucokinase, molecular secretagogues, such as glucagon, potassium, carbachol and ATP was outside the scope of this study. While the weight markers and G418 were from Gibco/BRL (Grand Island, NY, USA). All components required for prostatic incubations with glucose and agents that increase cAMP levels show definite responsiveness of the insulin duction of cDNA and RT/PCR analysis were purchased from Perkin/Elmer (Norwalk, CT, USA). Biosynthetic secretion in the HEP G2ins/g cells the dynamics of insulin release were demonstrated by the perifusion studies.
human proinsulin (hPI) and a polyclonal antibody to this peptide were kindly supplied by Lilly Research LaboraAs can be seen in Figure 8 , insulin was released as soon as the cells were exposed to glucose. Whilst the secretory tories (Indianapolis, IN, USA) . The radioimmunoassay for insulin was carried out with human insulin kindly using guinea pig insulin antibody and 125 I-labelled insulin prepared by the chloramine-T method. Cross-reacprovided by Novo Nordisk (Sydney, Australia), guinea pig insulin antibody donated by Professor D Yue and tivity with hPI was 73%; because of this, insulin values obtained have been appropriately reduced, and it is these iodinated insulin by Ms J Bryson, University of Sydney, Australia.
3 H-leucine was purchased from New England corrected values that are reported in the results. Serum controls with known amounts of insulin and proinsulin Biolabs (Ontario, Canada), guinea pig anti-insulin antibody and LSAB staining kit from Dako (Santa Barbara, were added to the assays as an added control for the relative amounts of insulin and proinsulin measured. Insulin CA, USA) and 8-Br-cAMP, theophylline and 3-(cyclohexylamino)-propanesulfonic acid from Sigma (St content of the cells was determined after overnight extraction in acid-ethanol. Albumin secretion of the cells Louis, MO, USA). Hybond C extra nylon membrane, the random priming kit for Northern blot analysis and the was measured using a Kallestad QM 300 rate nephelometer (Sanofi Diagnostics, Pasteur, USA). ECL chemiluminescent Western blotting kit were supplied by Amersham International (Amersham, Bucks, UK). The BioRad protein assay kit, nitrocellulose filter for RNA preparation and Northern (RNA) blot Total cellular RNA was isolated by the method of WilkinWestern blotting and the goat anti-rabbit horseradish peroxidase IgG conjugate were supplied by BioRad son. 36 Northern blot analysis was carried out as previously described. 3 Blots were hybridized sequentially (Richmond, CA, USA). The BCA protein assay kit was supplied by Pierce (Rockport, IL, USA). The Millipore with 32 P-labelled GLUT 2, insulin and glucokinase with stripping of the blot between hybridizations by boiling filters for electronmicroscopy were purchased from Millipore (Bedford, MA, USA), the LR White resin from Proin 0.1% sodium dodecyl sulfate (SDS) for 30 min. The blot was finally checked for gel loading by probing with bing and Structure (Brisbane, Australia), mouse antiinsulin and goat anti-mouse 10 nm gold from Biocell glyceraldehyde phosphate dehydrogenase (GAP) gene cDNA, as described.
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(Cardiff, UK).
Plasmid construction Analysis of gene expression by RT/PCR
Total RNA was isolated by the method of Wilkinson, 36 The transfection and characterization of the parental HEP G2ins cells is described. 3 Briefly, the full-length 0.6-kb or the guanidinium thiocyanate method. 38 For RT/PCR analysis RNA (1 g) was reverse-transcribed using human insulin cDNA was cloned into the multi-cloning site of pRcCMV (cytomegalovirus promoter) and transMoloney murine leukemia virus reverse transcriptase and random hexaneucleotide primers. 39 The PCR reaction fectants were selected in G418 antibiotic. In this study the full-length human 1.7 kb human GLUT 2 cDNA was was performed using a cDNA amount representing 100 ng total RNA and 1 unit of Amplitaq polymerase in a blunt-end ligated into the SmaI site of the expression vector pSKII + . The XhoI/BamHI 1.7 kb fragment was then reaction mix containing 10 mm Tris-HCl (pH 8.3), 50 mm KCl, 1.5 mm MgCl 2 , 0.01% (w/v) gelatin, 250 m dNTPs cloned into the multicloning site of pREP4 34 where cloned gene expression is under the control of the Rous sarcoma and 20 pmol of each primer. The PCR was performed in a Corbett thermal sequencer (Corbett, Sydney, Australia): virus long terminal repeat sequence. The pREP4 vector also carries the gene coding for resistance to the eucaryfollowing an initial denaturation step of 2 min at 94°C, a 35 cycle programme consisting of 94°C for 45 s, 61°C for ocidal antibiotic hygromycin B. Thus, the HEP G2ins/g cells were selected and perpetuated in both G418 and 1 min and 72°C for 45 s was performed. This was followed by a final cycle at 72°C for 5 min, before cooling hygromycin B.
to 4°C. Following PCR, a 10-l aliquot was subjected to 12% polyacrylamide gel electrophoresis, before ethidium Transfection of cell line HEP G2ins cells (5 × 10 6 ) 3 were transfected with 40 g of bromide staining and photography. The gene-specific human glucokinase forward PCR primer was the recombinant plasmid and vector, by electroporation (BioRad gene pulser, 200 V/cm, 960 F). Cells transfected 5′CTACTTGGAACAAATCGCCC, and the reverse PCR primer was 3′CCTCCT-CCTGGACTTCTTCC. This with the vector alone have been used as controls. Subsequently, 2.5 × 10 6 cells were plated into culture dishes primer pair generated a 155 bp PCR product from bp 244-379 of the published human glucokinase sequence.
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in minimal essential medium (MEM) containing 10% fetal calf serum (FCS). Cells were maintained under hygromySeveral negative control reactions were included in each experiment. Some of the negative controls contained cin B selection (500 g/ml) until hygromycin-resistant colonies were of sufficient size for Northern blot analysis.
water instead of cDNA, and other control reaction mixtures were prepared without the addition of RNA. All necessary precautions against contamination of PCRs Cell culture HEP G2 cells were grown as monolayers in MEM supwere rigorously observed.
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plemented with 10% FCS, HEP G2ins cells in the presence of 1 mg/ml G418 antibiotic and HEP G2ins/g cells in Membrane preparation, gel electrophoresis and Western blotting both G418 and 500 g/ml hygromycin, in air at 37°C.
Cell membranes were prepared from HEP G2, HEP G2ins and HEP G2ins/g cells by scraping the cells from the Cell extraction and radioimmunoassays (RIA) Samples of culture medium were collected for estimation tissue culture vessels with a rubber policeman. Cells were washed in Dulbecco's phosphate buffered saline (PBS), of insulin and human proinsulin (hPI) by radioimmunoassay (RIA) as described previously. 35 Iodinated hPI was resuspended in 0.01 m Tris/HCl, pH 7.4 containing 20 g/ml PMSF and homogenized. Homogenates were prepared by the chloramine-T method. Specificity was established by showing Ͻ0.05% cross-reactivity with centrifuged at 800 g for 10 min to remove nuclei and cell debris. The membranes were pelleted at 35 000 g for 60 insulin. The standard RIA for insulin was carried out min and resuspended in PBS containing PMSF (20 followed by six 15-min washes in 0.15 m phosphate buffer and dehydration in 70% ethanol (two treatments g/ml) and aproteinin 2 g/ml. All the above steps were carried out at 4°C. Protein determination was performed for 1 h each). The cells were then placed in a mixture of acrylic resin (LR White) 70% alcohol, 2:1 for 30 min, and with the BCA protein assay, using bovine serum albumin (BSA) as a standard.
subsequently in pure acrylic resin for 24 h at room temperature. Each sample was sealed in an airtight gelatin Membranes were resuspended in sample buffer (0.06 m Tris HCl, 25% glycerol, 2% SDS, 0.2% bromophenol capsule and stored at 48°C for 48 h. Serial ultrathin 100-130 nm sections were mounted on nickel grids. blue pH 6.8) and resolved on 10% SDS-polyacrylamide gel. Electrotransfer to a nitrocellulose filter (0.45 m)
The immunolocalization consisted of the following steps. Grids were placed in droplets of PBS for 10 min was performed overnight at 4°C using 1 mm 3-(cyclohexylamino)-propanesulfonic acid, 10% methanol, and then 5% BSA/PBS for 2 h before a 16-h incubation in primary antibody, mouse anti-insulin diluted 1:80 in pH 11 (CAPS) transfer buffer. The nitrocellulose was stained for 1 min with Ponceau S-1% acetic acid (to con-PGB (PBS, 1% glycine, 1% BSA, pH 7.4) solution at 4°C. Primary antibody was omitted from the negative controls firm adequate transfer of proteins) and destained in distilled water. The filters were blocked for 1 h in TBS (20 to ensure no nonspecific binding was taking place. The sections were then rinsed in two changes of PGB, pH 7.4, mm Tris (pH 7.4), 0.1% Tween, 5% nonfat dry milk) and washed for 1 h in TBS, 0.1% Tween. Incubation with the and once in PGB, pH 8.2. The grids were then incubated in goat anti-mouse 10 nm gold 1:50 in PGB, pH 8.2 for first antibody to human GLUT 2 (1:500) was for 2 h at room temperature in TBS, 0.5% skim milk. The filters 90 min. This was followed by four 10-min washes in PGB, pH 7.4 and four 10-min washes in PGB, pH 8.2. The secwere then washed at room temperature for 1 h in TBS, 0.1% Tween. The incubation in second antibody (goat tions were stained in 2% aqueous uranyl acetate for 20 min and washed thoroughly in distilled water before anti-rabbit horseradish peroxidase IgG conjugate (1:500)) was for 1 h at room temperature in 0.1% Tween, 5% nonexamination in a Philips CM 10 TEM (Philips, Eindhoven, The Netherlands). fat dry milk. The filters were finally washed for 1 h in TBS, 0.1% Tween. GLUT 2 protein expression was detected using the ECL chemiluminescent Western blotAcute stimulation of insulin secretion ting kit.
Static stimulation: Before stimulation, tissue culture plates were thoroughly washed with basal medium (PBS conImmunohistochemical analysis Immunohistochemical analysis for the presence of insulin taining 1 mm CaCl 2 and supplemented with 20 mm HEPES and 2 mg/ml BSA, 2.8 mm glucose (unless otherwas carried out on formalin-fixed samples of cultures that had been trypsinized, using a Dako LSAB 2 kit and wise stated) ) to remove culture medium and FCS. Monolayers were incubated in the basal medium at pH 7.4 for guinea pig anti-insulin. Before incubation in the primary antibody, all samples were blocked with goat serum to three consecutive 1-h periods to stabilize the basal secretion of insulin. Monolayers were then exposed to prevent nonspecific binding. A second incubation with rabbit anti-guinea pig antibody was followed by a final stimuli for 1 h. Glucose (20 mm), 5 mm 8-Br-cAMP and 10 mm theophylline were dissolved in basal medium, incubation with biotinylated anti-rabbit antibody and horseradish peroxidase, labelled streptavidin/3-amino-9-TPA: 1.3 m (Sigma) was dissolved in dimethylsulphoxide (DMSO) and diluted in basal medium (DMSO final ethylcarbazole. The counterstain was red/pink Mayer's haematoxylin. Primary antibody was omitted from the concentration 0.8%). Calcium (10 mm) was dissolved in basal medium without phosphate. Three controls were procedure, as a negative control and the positive control were mouse islets.
used: basal medium alone, medium with 0.8% DMSO and basal medium without phosphate.
To construct the dose-response curve to glucose, the Electron microscopy After trypsinization, a single cell suspension of control basal level of insulin secretion was established as described above and the monolayers were exposed to HEP G2 cells and HEP G2ins/g cells were diluted 1:1 with fixative at room temperature, packed on to 0.65 m increasing concentrations of glucose from 0-20 mm over 1-h periods. pore size Millipore filters and fixed for a total of 1 h at 4°C. The fixative contained 3% glutaraldehyde, 1% formalin, 0.13 m sucrose, with or without 21 mm betaine in Dynamic stimulation: Cells were trypsinized and attached to cytodex 3 beads and cultured in spinner flasks in 0.17 m Hepes buffer, pH 7.4, osmolality 1056 mOsM with, and 1041 without betaine. Measurement of granule size MEM, for a period of 5 days. Beads with cells attached were transferred to a 1-ml syringe, connected to a periwas from cells processed with betaine in the fixative, as this gave superior preservation of ultrastructure. Further staltic pump and fraction collector, and basal medium was pumped through the system. This was followed by processing was as described previously. 3 Grey ultrathin sections were stained with uranyl acetate and lead citrate, a 30-min stimulus with 20 mm glucose and a further 30-min basal period. Samples were collected every 2 min and examined in a JEM-1010 TEM (Jeol, Tokyo, Japan) at 80 kv.
and assayed for insulin. For immunoelectronmicroscopy, after trypsinization single cell suspensions of control HEP G2 cells, HEP Insulin synthesis G2ins/g and NIT-1 (mouse insulinoma cell line, used as control for the immunogold technique and for compariDose-response curve to glucose: After trypsinization 10 6 HEP G2ins/g cells were incubated at 37°C (5% CO 2 /95% son to transfected hepatoma cells) 41 cells were pelleted by centrifugation and fixed in 2% paraformaldehyde in O 2 ) in vials containing 2 ml Krebs-Ringer bicarbonate buffer supplemented with 10 mm HEPES, 2 mg ml BSA 0.15 m phosphate buffer, at room temperature. This was (KRB/BSA), 50 Ci/ml l- [4,5- 3 H] leucine and 20 mm glu-
